The incidence of neurodevelopmental impairment is high in survivors of twin-to-twin transfusion syndrome treated with laser surgery, researchers report in the March issue of the American Journal of Obstetrics & Gynecology.
The incidence of neurodevelopmental impairment is high in survivors of twin-to-twin transfusion syndrome treated with laser surgery, researchers report in the March issue of the American Journal of Obstetrics & Gynecology.
Frans J. Walther, MD, PhD, of Leiden University Medical Center in the Netherlands, and colleagues examined the long-term neurodevelopmental outcomes of 82 twin-to-twin transfusion syndrome pregnancies treated with fetoscopic laser surgery.
The researchers found a 70% perinatal survival rate. Neurodevelopmental impairment due to cerebral palsy, mental developmental delay, psychomotor developmental delay, or deafness was present in 17% of cases at 2 years of age.
Lopriore E, Middeldorp JM, Sueters M, et al. Long-term neurodevelopmental outcome in twin-to-twin transfusion syndrome treated with fetoscopic laser surgery. Am J Obstet Gynecol. 2007;196:231.e1-231.e4.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More